BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15083556)

  • 21. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.
    Tyndall MW; Kerr T; Zhang R; King E; Montaner JG; Wood E
    Drug Alcohol Depend; 2006 Jul; 83(3):193-8. PubMed ID: 16356659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting biopsychosocial outcomes for heroin users in primary care treatment: a prospective longitudinal cohort study.
    Parmenter J; Mitchell C; Keen J; Oliver P; Rowse G; Neligan I; Keil C; Mathers N
    Br J Gen Pract; 2013 Jul; 63(612):e499-505. PubMed ID: 23834887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychiatric symptoms, health services, and HIV risk factors among homeless women.
    Kilbourne AM; Herndon B; Andersen RM; Wenzel SL; Gelberg L
    J Health Care Poor Underserved; 2002 Feb; 13(1):49-65. PubMed ID: 11836913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disparities in use of mental health and substance abuse services by persons with co-occurring disorders.
    Havassy BE; Alvidrez J; Mericle AA
    Psychiatr Serv; 2009 Feb; 60(2):217-23. PubMed ID: 19176416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatic health among heroin addicts before and during opioid maintenance treatment: a retrospective cohort study.
    Skeie I; Brekke M; Lindbaek M; Waal H
    BMC Public Health; 2008 Jan; 8():43. PubMed ID: 18237421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Characteristics of heroin dependent patients admitted to a methadone treatment program].
    Sanvisens A; Rivas I; Faure E; Muñoz T; Rubio M; Fuster D; Tor J; Muga R
    Med Clin (Barc); 2014 Jan; 142(2):53-8. PubMed ID: 23337454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with drug treatment dropout among injection drug users in Puerto Rico.
    Marrero CA; Robles RR; Colón HM; Reyes JC; Matos TD; Sahai H; Calderón JM; Shepard EW
    Addict Behav; 2005 Feb; 30(2):397-402. PubMed ID: 15621413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification.
    Gruber VA; Delucchi KL; Kielstein A; Batki SL
    Drug Alcohol Depend; 2008 Apr; 94(1-3):199-206. PubMed ID: 18243585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linkage to methadone treatment from acute opiate detoxification treatment.
    Zaller ND; Thurmond P; Brett J; Carleton JC; Rich JD
    J Opioid Manag; 2006; 2(6):341-6. PubMed ID: 17326596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Injection frequency mediates health service use among persons with a history of drug injection.
    Stein MD; Anderson B
    Drug Alcohol Depend; 2003 May; 70(2):159-68. PubMed ID: 12732409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating the effects of San Francisco's Treatment on Demand Initiative on a publicly-funded substance abuse treatment system: a time series analysis.
    Sears C; Davis T; Guydish J; Gleghorn A
    J Psychoactive Drugs; 2009 Sep; 41(3):297-304. PubMed ID: 19999683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Ettner SL;
    J Acquir Immune Defic Syndr; 2008 Apr; 47(4):449-58. PubMed ID: 18197121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver.
    Kerr T; Marsh D; Li K; Montaner J; Wood E
    Drug Alcohol Depend; 2005 Dec; 80(3):329-35. PubMed ID: 15964714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.
    Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
    J Epidemiol Community Health; 1996 Oct; 50(5):534-7. PubMed ID: 8944860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-efficacy and HIV risk behaviors among heroin users in Taiwan.
    Ko NY; Wang PW; Wu HC; Yen CN; Hsu ST; Yeh YC; Chung KS; Yen CF
    J Stud Alcohol Drugs; 2012 May; 73(3):469-76. PubMed ID: 22456252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rhabdomyolysis and brain ischemic stroke in a heroin-dependent male. Invited comment.
    Somala RK
    Acta Psychiatr Scand; 2009 Jul; 120(1):80-1. PubMed ID: 19519677
    [No Abstract]   [Full Text] [Related]  

  • 37. Case study: accessible primary health care--a foundation to improve health outcomes for people who inject drugs.
    van Beek I
    Int J Drug Policy; 2007 Aug; 18(4):329-32. PubMed ID: 17689383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multilevel analysis of HIV related risk behaviors among heroin users in a low prevalence community.
    Li H; Goggins W; Lee SS
    BMC Public Health; 2009 May; 9():137. PubMed ID: 19435512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment programs in the National Drug Abuse Treatment Clinical Trials Network.
    McCarty D; Fuller B; Kaskutas LA; Wendt WW; Nunes EV; Miller M; Forman R; Magruder KM; Arfken C; Copersino M; Floyd A; Sindelar J; Edmundson E
    Drug Alcohol Depend; 2008 Jan; 92(1-3):200-7. PubMed ID: 17875368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Participation dynamics of a cohort of drug users in a low-threshold methadone treatment programme.
    Kwan TH; Wong NS; Lee SS
    Harm Reduct J; 2015 Oct; 12():30. PubMed ID: 26470863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.